AMGN vs IDXX
By Alex · Tickerpine
Amgen Inc. vs IDEXX Laboratories, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | IDXX |
|---|---|---|
| Price | $416.18 | $570.58 |
| Market cap | $225.15B | $44.95B |
| P/E ratio | 25.7 | 41.1 |
| ROE | 91.47% | 74.21% |
| Profit margin | 22.95% | 25.03% |
| Revenue growth | 9.50% | 9.70% |
| Dividend yield | 2.43% | — |
| Beta | 0.41 | 1.54 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs IDXX in plain English
- AMGN is the bigger company — about 5.0× the market cap of IDXX.
- AMGN is cheaper on earnings (P/E 25.7 vs 41.1).
- AMGN earns a higher return on equity (91% vs 74%).
- IDXX is growing revenue faster (10% vs 10%).
- AMGN pays a dividend (2.43%) while the other effectively doesn't.
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
IDXX return calculator
See what $1,000 in IDEXX Laboratories, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.